As shown in the plot, we found that almost all patients from the high-risk subgroup had the C4 immune subtype, tumor grade 3 or 4, and high mortality, with a higher proportion of poor prognostic factors such as IDH wild type, 1p19q non-codeletion, and MGMT unmethylation. This evidence concerns the gene MGMT and neoplasm.